Outreach and Connection to Care for Chronic Kidney Disease in a Workplace Wellness Setting: A Cost-Effectiveness Analysis

被引:0
|
作者
Li, Yonghong [1 ]
Devlin, James J. [1 ]
机构
[1] Quest Diagnost, 33608 Ortega Highway, San Juan Capistrano, CA 92675 USA
关键词
chronic kidney disease; cost-effectiveness analysis; Markov modeling; CARDIOVASCULAR OUTCOMES; NEPHROPATHY; INHIBITORS;
D O I
10.1089/pop.2019.0206
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Because chronic kidney disease (CKD) is underdiagnosed, many patients do not receive care that could slow or prevent progression. Potential CKD patients can be identified during employee wellness events and referred into care by a CKD outreach program. This study assessed the health and economic benefits associated with a CKD outreach program. A model-based cost-effectiveness analysis was conducted for a cohort of patients at risk for CKD under 2 scenarios: wellness events with a CKD outreach program and wellness events without outreach. The outreach program identified potential CKD patients based on estimated glomerular filtration rates. Health outcomes and total cost to payers were estimated with Markov models using 1-year cycles. Because outreach could be offered to either patients with diabetes or to all potential CKD patients, these groups were modeled separately. The authors assumed 40% percent of potential CKD patients accepted the invitation to participate in the CKD outreach program. Model parameters were taken from peer-reviewed literature. The study was conducted from the perspective of self-insured employers over a 5-year time horizon. The study found that the CKD outreach program resulted in a gain of 2.3 quality-adjusted life-years and saved $500,211 when 1000 potential CKD patients with diabetes were invited. When potential CKD patients were invited without regard for diabetes status, 0.8 quality-adjusted life-years were gained at a cost savings of $34,161. The authors concluded that CKD outreach programs can improve health outcomes for patients with CKD and save costs for payers.
引用
下载
收藏
页码:487 / 494
页数:8
相关论文
共 50 条
  • [1] SCREENING FOR CHRONIC KIDNEY DISEASE AND CONNECTION TO CARE IN A WORKPLACE WELLNESS SETTING: A COST EFFECTIVENESS ANALYSIS
    Li, Y.
    Devlin, J. J.
    VALUE IN HEALTH, 2019, 22 : S383 - S383
  • [2] Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease
    Hopkins, Robert B.
    Garg, Amit X.
    Levin, Adeera
    Molzahn, Anita
    Rigatto, Claudio
    Singer, Joel
    Soltys, George
    Soroka, Steven
    Parfrey, Patrick S.
    Barrett, Brendan J.
    Goeree, Ron
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (06): : 1248 - 1257
  • [3] COST-EFFECTIVENESS ANALYSIS OF TREATMENTS IN CHRONIC KIDNEY DISEASE IN MEXICO
    Frias Gasga, A. E.
    Cortes-Sanabria, L.
    Rueda Galicia, C.
    Soto, H.
    Guzman Vazquez, S.
    VALUE IN HEALTH, 2022, 25 (07) : S393 - S394
  • [4] Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran
    Ravaghi, Hamid
    Farzaneh, Ali
    Ebrahimnia, Mehdi
    Rostami, Zohreh
    Madani, Mohammad Hasan Hashemi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (11) : IC01 - IC04
  • [5] Cost-effectiveness analysis of dapagliflozin for people with chronic kidney disease in Malaysia
    Lim, Soo Kun
    Lee, Shaun Wen Huey
    PLOS ONE, 2024, 19 (03):
  • [6] Use of surrogacy for women with chronic kidney disease: a cost-effectiveness analysis
    Farwell, Jennifer
    Wyatt, Solange
    Rueda, Jose
    Emerson, Jenna
    Page, Jessica
    Fowler, Jessica
    Allen, Allison
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S153 - S153
  • [7] Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan
    Kodera, Satoshi
    Morita, Hiroyuki
    Nishi, Hiroshi
    Takeda, Norifumi
    Ando, Jiro
    Komuro, Issei
    CIRCULATION JOURNAL, 2022, 86 (12) : 2021 - +
  • [8] Population-Wide Screening for Chronic Kidney Disease A Cost-Effectiveness Analysis
    Cusick, Marika M.
    Tisdale, Rebecca L.
    Chertow, Glenn M.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (06) : 788 - +
  • [9] COST-EFFECTIVENESS ANALYSIS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE WITH LOW PROTEIN DIET
    Mennini, Francesco
    Russo, Simone
    Marcellusi, Andrea
    Quintaliani, Giuseppe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 164 - 164
  • [10] The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
    Yarnoff, Benjamin O.
    Hoerger, Thomas J.
    Simpson, Siobhan A.
    Pavkov, Meda E.
    Burrows, Nilka R.
    Shrestha, Sundar S.
    Williams, Desmond E.
    Zhuo, Xiaohui
    PLOS ONE, 2016, 11 (07):